NCT03036046View on ClinicalTrials.gov

Safety and Pharmacokinetics of Oral F901318 (Fluconazole and Posaconazole) IN Aml Leukaemia

PHASE1/PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

March 31, 2017

Primary Completion Date

September 30, 2017

Study Completion Date

March 31, 2018

Conditions
Acute Myeloid Leukemia
Interventions
DRUG

F901318 with fluconazole low dose

adverse events

DRUG

F901318 with fluconazole high dose

adverse events

DRUG

F901318 with posaconazole

adverse events

Sponsors

Lead Sponsor

F2G Biotech GmbH
All Listed Sponsors
collaborator

The Clinical Trials Centre Cologne

OTHER

collaborator

Klinik für Hämatologie, Aachen

UNKNOWN

collaborator

Medizinische Klinik Würzburg

UNKNOWN

lead

F2G Biotech GmbH

INDUSTRY